MedTrace Logo

Observational Study in Patients Suffering From Benign Prostatic Hyperplasia Treated With Alpha-adrenergic Blockade

NCT02244307 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4561

Last updated 2014-09-19

No results posted yet for this study

Summary

The primary objective of this observational study was the assessment of prognosis factors for having recourse to prostatic surgery in patients with BPH who were administered class-1 alpha blockers. The secondary objectives were the assessment of the time from alpha-adrenergic blockade treatment initiation to surgery and the evolution of patients during the study.

Conditions

  • Prostatic Hyperplasia

Interventions

DRUG

alpha-adrenergic blocker

Sponsors & Collaborators

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-01-31
Primary Completion
2003-06-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02244307 on ClinicalTrials.gov